Article Review: Comparison of 64Cu DOTA PSMA 3Q and 64Cu NOTA PSMA 3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer preclinical assessment and preliminary clinical PET CT imaging

Objectives Compared the efficacy and safety of 64Cu-labeled PSMA-3Q using NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) and DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) as bifunctional chelating agents (BFCAs) in prostate ca...